PE20010229A1 - PYRIMIDONES SUBSTITUTED FOR ARYLS AND POLYCYCLIC HETEROARYLS USEFUL FOR THE SELECTIVE INHIBITION OF THE COAGULATION CASCADE - Google Patents
PYRIMIDONES SUBSTITUTED FOR ARYLS AND POLYCYCLIC HETEROARYLS USEFUL FOR THE SELECTIVE INHIBITION OF THE COAGULATION CASCADEInfo
- Publication number
- PE20010229A1 PE20010229A1 PE2000000575A PE0005752000A PE20010229A1 PE 20010229 A1 PE20010229 A1 PE 20010229A1 PE 2000000575 A PE2000000575 A PE 2000000575A PE 0005752000 A PE0005752000 A PE 0005752000A PE 20010229 A1 PE20010229 A1 PE 20010229A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- aryls
- coagulation cascade
- substituted
- group
- Prior art date
Links
- 150000008318 pyrimidones Chemical group 0.000 title abstract 3
- 230000015271 coagulation Effects 0.000 title abstract 2
- 238000005345 coagulation Methods 0.000 title abstract 2
- 230000005764 inhibitory process Effects 0.000 title 1
- 229910052799 carbon Inorganic materials 0.000 abstract 3
- 229910052760 oxygen Inorganic materials 0.000 abstract 3
- 229910052717 sulfur Inorganic materials 0.000 abstract 3
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- -1 AMINO Chemical class 0.000 abstract 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical class N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 abstract 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 abstract 1
- 102000012479 Serine Proteases Human genes 0.000 abstract 1
- 108010022999 Serine Proteases Proteins 0.000 abstract 1
- 150000001409 amidines Chemical class 0.000 abstract 1
- 208000026106 cerebrovascular disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000001732 thrombotic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
Abstract
SE REFIERE A PIRIMIDONAS SUSTITUIDAS DE ARILOS Y HETEROARILOS POLICICLICOS DE FORMULA I, DONDE: B ES UN GRUPO b; R9-R13, R32-R36 SON ACETAMIDO, HALOACETAMIDO, ENTRE OTROS; R9-R13 SON HETEROARILO, HETEROCICLILO SI R9-R13 NO SON SUSTITUYENTES DE B; R16, R19, R32-R36 SON Qb, UNO DE R16 Y R19 ES Qb Y Qb ES Qbe; B ES TRIALQUILSILILO, ALQUILO C2-C8, ENTRE OTROS; A ES UN ENLACE, (W7)rr-(CH(R15))pa, ENTRE OTROS; rr ES 0-1; pa ES 0-6; W7 ES O, S, C(O), (R7)NC(O), ENTRE OTROS; R7 ES OH, ALQUILO; R15 ES OH, HALO, ALQUILO, HALOALQUILO; ES NH, NOH; M ES N, R1-C; R1 ES ALQUILO, CIANO, ENTRE OTROS; R2 ES Z°-Q; Z° ES (CR41R42)q; q ES 1-3; R41 Y R42 SON AMIDINO, HIDROXIAMINO, ENTRE OTROS; Q ES UN GRUPO II; D1, D2, J1, J2, K1 SON C, N, O, S, UN ENLACE; K ES (CR4aRb)n; n ES 1-2; R4a Y R4b SON HALO, HIDROXIALQUILO, ALQUILO; E° ES E1; E1 ES CO, CS, CONR7, SO2, ENTRE OTROS; Y° ES GRUPO IV, ENTRE OTROS; D5, D6, J5, J6 SON C, N, O, S, ENTRE OTROS; Qb ES AMINOALQUILENILO, ENTRE OTROS; Qbe ES NR6CNR25NR23R24, ENTRE OTROS. NO MAS DE UNO DE R20 Y R21 o R23 Y R24 SON OH, AMINO, ENTRE OTROS; R20 A R26 SON ALQUILO, OH, ENTRE OTROS. LOS COMPUESTOS DE PIRIMIDONAS SUSTITUIDAS SON INHIBIDORES DE PROTEASAS DE SERINA DE LA CASCADA DE COAGULACION POR LO QUE PUEDEN SER UTILES PARA EL TRATAMIENTO DE ENFERMEDADES TROMBOTICAS, CORONARIAS, CEREBROVASCULARESREFERS TO PYRIMIDONES SUBSTITUTED FOR ARYLS AND POLYCYCLIC HETEROARYLS OF FORMULA I, WHERE: B IS A GROUP b; R9-R13, R32-R36 ARE ACETAMIDE, HALOACETAMIDE, AMONG OTHERS; R9-R13 ARE HETEROARYL, HETERO CYCLYL IF R9-R13 ARE NOT A SUBSTITUTE FOR B; R16, R19, R32-R36 ARE Qb, ONE OF R16 AND R19 IS Qb AND Qb IS Qbe; B IS TRIALKYSILYL, C2-C8 ALKYL, AMONG OTHERS; A IS A LINK, (W7) rr- (CH (R15)) pa, AMONG OTHERS; rr IS 0-1; pa IS 0-6; W7 IS O, S, C (O), (R7) NC (O), AMONG OTHERS; R7 IS OH, ALKYL; R15 IS OH, HALO, ALKYL, HALOALKYL; IS NH, NOH; M IS N, R1-C; R1 IS ALKYL, CYANO, AMONG OTHERS; R2 IS Z ° -Q; Z ° ES (CR41R42) q; q IS 1-3; R41 AND R42 ARE AMIDINE, HYDROXYAMINE, AMONG OTHERS; Q IS A GROUP II; D1, D2, J1, J2, K1 ARE C, N, O, S, A LINK; K IS (CR4aRb) n; n IS 1-2; R4a AND R4b ARE HALO, HYDROXYALKYL, ALKYL; E ° IS E1; E1 IS CO, CS, CONR7, SO2, AMONG OTHERS; Y ° IS GROUP IV, AMONG OTHERS; D5, D6, J5, J6 ARE C, N, O, S, AMONG OTHERS; Qb IS AMINOALKYLENYL, AMONG OTHERS; Qbe IS NR6CNR25NR23R24, AMONG OTHERS. NO MORE THAN ONE OF R20 AND R21 or R23 AND R24 ARE OH, AMINO, AMONG OTHERS; R20 TO R26 ARE ALKYL, OH, AMONG OTHERS. SUBSTITUTED PYRIMIDONE COMPOUNDS ARE INHIBITORS OF SERINE PROTEASES FROM THE COAGULATION CASCADE SO THEY MAY BE USEFUL FOR THE TREATMENT OF THROMBOTIC, CORONARY, CEREBROVASCULAR DISEASES
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13479499P | 1999-05-19 | 1999-05-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20010229A1 true PE20010229A1 (en) | 2001-03-07 |
Family
ID=22465042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000000575A PE20010229A1 (en) | 1999-05-19 | 2000-06-09 | PYRIMIDONES SUBSTITUTED FOR ARYLS AND POLYCYCLIC HETEROARYLS USEFUL FOR THE SELECTIVE INHIBITION OF THE COAGULATION CASCADE |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1178970A1 (en) |
| JP (1) | JP2002544262A (en) |
| KR (1) | KR20010114271A (en) |
| CN (1) | CN1157380C (en) |
| AR (1) | AR030021A1 (en) |
| AU (2) | AU771718B2 (en) |
| BR (1) | BR0010758A (en) |
| CA (1) | CA2373614A1 (en) |
| CZ (1) | CZ20014116A3 (en) |
| EA (1) | EA004867B1 (en) |
| HU (1) | HUP0201242A3 (en) |
| IL (1) | IL146243A0 (en) |
| MX (1) | MXPA01011804A (en) |
| NO (1) | NO20015604L (en) |
| NZ (1) | NZ514874A (en) |
| PE (1) | PE20010229A1 (en) |
| PL (1) | PL352827A1 (en) |
| SK (1) | SK15852001A3 (en) |
| TW (1) | TWI222445B (en) |
| UY (1) | UY26156A1 (en) |
| WO (1) | WO2000069832A1 (en) |
| ZA (2) | ZA200109339B (en) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6750342B1 (en) | 1999-05-19 | 2004-06-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
| US6716838B1 (en) | 1999-05-19 | 2004-04-06 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
| US6653316B1 (en) | 1999-05-19 | 2003-11-25 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
| KR20010113969A (en) * | 1999-05-19 | 2001-12-28 | 추후보정 | Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
| US7015230B1 (en) | 1999-05-19 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
| US6664255B1 (en) | 1999-05-19 | 2003-12-16 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| US6458952B1 (en) | 1999-05-19 | 2002-10-01 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade |
| US6867217B1 (en) | 1999-05-19 | 2005-03-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
| US6852761B2 (en) | 2000-03-13 | 2005-02-08 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade |
| CA2405561A1 (en) | 2000-04-05 | 2001-10-18 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade |
| EP1268428A2 (en) | 2000-04-05 | 2003-01-02 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |
| US6686484B2 (en) | 2000-04-17 | 2004-02-03 | Pharmacia Corporation | Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade |
| WO2001087851A1 (en) * | 2000-05-18 | 2001-11-22 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
| US6710058B2 (en) | 2000-11-06 | 2004-03-23 | Bristol-Myers Squibb Pharma Company | Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors |
| US7015223B1 (en) | 2000-11-20 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade |
| US7119094B1 (en) | 2000-11-20 | 2006-10-10 | Warner-Lambert Company | Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade |
| MXPA03004458A (en) | 2000-11-20 | 2005-01-25 | Pharmacia Corp | Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade. |
| WO2003029216A1 (en) | 2001-10-03 | 2003-04-10 | Pharmacia Corporation | 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| WO2003029224A1 (en) * | 2001-10-03 | 2003-04-10 | Pharmacia Corporation | 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| AU2002367752A1 (en) | 2001-10-03 | 2003-11-17 | Pharmacia Corporation | Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| JP2005532268A (en) | 2002-02-22 | 2005-10-27 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | Substituted pyrimidinones and pyrimidinethiones |
| TW200307667A (en) | 2002-05-06 | 2003-12-16 | Bristol Myers Squibb Co | Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
| US7217794B2 (en) | 2003-04-02 | 2007-05-15 | Daiamed, Inc. | Compounds and methods for treatment of thrombosis |
| US7182738B2 (en) | 2003-04-23 | 2007-02-27 | Marctec, Llc | Patient monitoring apparatus and method for orthosis and other devices |
| CA2610400A1 (en) * | 2005-06-07 | 2006-12-14 | Pharmacopeia, Inc. | Azinone and diazinone v3 inhibitors for depression and stress disorders |
| CN104311537B (en) * | 2014-09-19 | 2016-08-24 | 广东东阳光药业有限公司 | Containing pyrimidone acetyl substituents pyrazole compound and combinations thereof thing and purposes |
| AU2020396565C1 (en) * | 2019-12-04 | 2025-05-15 | Omeros Corporation | MASP-2 inhibitors and methods of use |
| CN115779953B (en) * | 2022-12-19 | 2024-06-21 | 中南大学 | Copper-loaded carbon-based monoatomic material, and preparation method and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5441960A (en) * | 1992-04-16 | 1995-08-15 | Zeneca Limited | 1-pyrimidinylacetamide human leukocyte elastate inhibitors |
| US5948785A (en) * | 1995-04-27 | 1999-09-07 | The Green Cross Corporation | Heterocyclic amide compounds and pharmaceutical use of the same |
-
2000
- 2000-05-17 JP JP2000618249A patent/JP2002544262A/en active Pending
- 2000-05-17 CN CNB008077479A patent/CN1157380C/en not_active Expired - Fee Related
- 2000-05-17 WO PCT/US2000/009806 patent/WO2000069832A1/en not_active Ceased
- 2000-05-17 CA CA002373614A patent/CA2373614A1/en not_active Abandoned
- 2000-05-17 PL PL00352827A patent/PL352827A1/en not_active Application Discontinuation
- 2000-05-17 AU AU49734/00A patent/AU771718B2/en not_active Ceased
- 2000-05-17 KR KR1020017014753A patent/KR20010114271A/en not_active Withdrawn
- 2000-05-17 BR BR0010758-1A patent/BR0010758A/en not_active IP Right Cessation
- 2000-05-17 NZ NZ514874A patent/NZ514874A/en unknown
- 2000-05-17 IL IL14624300A patent/IL146243A0/en unknown
- 2000-05-17 EP EP00931928A patent/EP1178970A1/en not_active Withdrawn
- 2000-05-17 EA EA200101214A patent/EA004867B1/en not_active IP Right Cessation
- 2000-05-17 SK SK1585-2001A patent/SK15852001A3/en unknown
- 2000-05-17 HU HU0201242A patent/HUP0201242A3/en unknown
- 2000-05-17 CZ CZ20014116A patent/CZ20014116A3/en unknown
- 2000-05-17 MX MXPA01011804A patent/MXPA01011804A/en unknown
- 2000-05-19 AR ARP000102446A patent/AR030021A1/en unknown
- 2000-05-19 UY UY26156A patent/UY26156A1/en not_active Application Discontinuation
- 2000-06-09 PE PE2000000575A patent/PE20010229A1/en not_active Application Discontinuation
- 2000-07-25 TW TW089109595A patent/TWI222445B/en not_active IP Right Cessation
-
2001
- 2001-11-13 ZA ZA200109339A patent/ZA200109339B/en unknown
- 2001-11-16 NO NO20015604A patent/NO20015604L/en not_active Application Discontinuation
-
2004
- 2004-01-21 ZA ZA200400448A patent/ZA200400448B/en unknown
- 2004-05-31 AU AU2004202375A patent/AU2004202375A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU771718B2 (en) | 2004-04-01 |
| AR030021A1 (en) | 2003-08-13 |
| UY26156A1 (en) | 2000-12-29 |
| BR0010758A (en) | 2003-06-10 |
| HUP0201242A2 (en) | 2002-12-28 |
| TWI222445B (en) | 2004-10-21 |
| EA200101214A1 (en) | 2002-06-27 |
| KR20010114271A (en) | 2001-12-31 |
| NZ514874A (en) | 2004-11-26 |
| AU2004202375A1 (en) | 2004-06-24 |
| AU4973400A (en) | 2000-12-05 |
| ZA200400448B (en) | 2004-09-29 |
| EP1178970A1 (en) | 2002-02-13 |
| EA004867B1 (en) | 2004-08-26 |
| SK15852001A3 (en) | 2003-06-03 |
| HUP0201242A3 (en) | 2003-02-28 |
| WO2000069832A1 (en) | 2000-11-23 |
| PL352827A1 (en) | 2003-09-08 |
| NO20015604L (en) | 2002-01-11 |
| IL146243A0 (en) | 2002-07-25 |
| ZA200109339B (en) | 2004-05-26 |
| CN1351593A (en) | 2002-05-29 |
| NO20015604D0 (en) | 2001-11-16 |
| CZ20014116A3 (en) | 2002-06-12 |
| CN1157380C (en) | 2004-07-14 |
| CA2373614A1 (en) | 2000-11-23 |
| JP2002544262A (en) | 2002-12-24 |
| MXPA01011804A (en) | 2003-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20010229A1 (en) | PYRIMIDONES SUBSTITUTED FOR ARYLS AND POLYCYCLIC HETEROARYLS USEFUL FOR THE SELECTIVE INHIBITION OF THE COAGULATION CASCADE | |
| PE20010290A1 (en) | POLYCYCLIC ARYLS AND HETEROARYLS SUBSTITUTED PIRAZINONES USEFUL FOR THE SELECTIVE INHIBITION OF THE COAGULATION CASCADE | |
| PE20010217A1 (en) | URACILS SUBSTITUTED FOR ARYLS AND POLYCYCLIC HETEROARYLS USEFUL FOR THE SELECTIVE INHIBITION OF THE COAGULATION CASCADE | |
| MX9200817A (en) | DERIVATIVES OF PIRANIL CYANOGUANIDINE AND PROCESS FOR ITS PREPARATION. | |
| TR199802767T2 (en) | New amidino derivatives as thrombin inhibitors. | |
| AR026102A1 (en) | A PROCESS TO STABILIZE A POLYETHYLENE MOCROLLIDE, A SOLID FORM MIX, A PHARMACEUTICAL COMPOSITION, A RAPAMYCIN DERIVATIVE AND A PROCESS TO PURIFY | |
| NO950168D0 (en) | O-benzyloxime derivatives and their use as pesticides | |
| MY136789A (en) | Metalloproteinase inhibitors | |
| NO982748D0 (en) | Procedure for nitrogen removal from combustion exhaust gases | |
| ATE134644T1 (en) | OTHER ANTIVIRAL PYRIMIDINE NUCLEOSIDES | |
| ES2086326T3 (en) | METHOD FOR INTENSIFYING CHEMILUMINESCENCE. | |
| PT1152993E (en) | PROCESS FOR THE MANUFACTURE OF A HYDRAULIC BINDER BASED ON NITRITE III OR ALPHA AND THE HYDRAULIC BINDER SO OBTAINED | |
| DE69128477D1 (en) | BENZOPYRANDERIVAT | |
| DK0595557T3 (en) | Novel substituted azetidones as anti-inflammatory and anti-degenerative agents | |
| ES8802223A1 (en) | 2-Oxy-4H-3,1-benzoxazin-4-one derivatives and related compounds. | |
| DE3786961D1 (en) | ALPHA-1-ANTITRYPSIN VERSIONS, ESPECIALLY APPLICABLE AS CALLICINE INHIBITORS. | |
| NO975679L (en) | Process for Preparation of N-Monosubstituted and N, N'-Disubstituted Unsymmetrical Cyclic Urea | |
| FI901610A0 (en) | FOERFARANDE FOER MALNING AV PORTLANDCEMENTKLINKER FOER FRAMSTAELLNING AV GIPSFRIA PORTLANDCEMENTER. | |
| DK666689A (en) | MODIFIED CRYSTALLINIC ALUMINOSILICATE AND PROCEDURE FOR PREPARING THE SAME | |
| IL155958A0 (en) | Cysteine protease inhibitors | |
| ES2094521T3 (en) | PROCEDURE FOR THE OBTAINING OF A TETRAHYDRO-3,5-DIMETHYL-1,3,5-TIADIAZIN-2-TIONA GRANULATE WIDELY FREE OF DUST. | |
| PE20000474A1 (en) | INHIBITORS OF NITRIC OXIDE SYNTHASE | |
| FR2753972B1 (en) | LACTITOL COMPOSITION AND PROCESS FOR THE PREPARATION THEREOF | |
| DE3378978D1 (en) | TETRAHYDRO-BENZO (E) ISOINDOLINES | |
| PE20010201A1 (en) | PYRIDONES SUBSTITUTED FOR POLYCYCLIC ARILO AND HETEROARYLUS THAT ARE USEFUL FOR THE SELECTIVE INHIBITION OF THE COAGULATION CASCADE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |